Alvotech (ALVO) vs Pharvaris N.V. (PHVS)

A side-by-side comparison of Alvotech and Pharvaris N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alvotech logo
ALVO
Alvotech
$2.06B
$6.08HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Pharvaris N.V. logo
PHVS
Pharvaris N.V.
$2.16B
$30.98HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — ALVO vs PHVS

growth of $100 · dividends reinvested · last 4y
ALVO -45.4% (-14.0%/yr)PHVS +43.6% (+9.5%/yr)PHVS compounded faster over this window
050100150Start $1002023202420252026$55$144
ALVO PHVS

ALVO vs PHVS: by the numbers

  • •PHVS is the larger company ($2.16B vs $2.06B market cap).
  • •Both run net losses; PHVS's is the smaller (0.00% vs -36.51% net margin).

Metrics side by side

Valuation

MetricALVOPHVS
P/S ratio4.18N/A
P/B ratioN/A6.30
EV / EBITDA41.71N/A

Profitability

MetricALVOPHVS
Gross margin60.45%0.00%
Operating margin9.62%0.00%
Net margin-36.51%0.00%
ROEN/A-57.96%
ROIC3.61%-61.74%

Growth (annualized)

MetricALVOPHVS
Revenue CAGR (5Y)69.03%N/A
Total return CAGR (5Y)N/A11.45%

Go deeper

Full ALVO analysisFull PHVS analysisInteractive comparison tool

Dig into the metrics

Alvotech ROEPharvaris ROEAlvotech operating marginPharvaris operating marginAlvotech revenue growthPharvaris revenue growthAlvotech free cash flowPharvaris free cash flow

Alvotech & Pharvaris appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.